糖尿病性黄斑水肿的治疗进展  

Progress in the treatment of diabetic macular edema

作　　者：强甜甜 高自清[1] Qiang Tiantian;Gao Ziqing(Ophthalmology department,the first affiliated hospital of Bengbu Medical College,,Bengbu,Anhui,233004,China;Post graduate school of Bengbu Medical College,Bengbu,Anhui,233004,China)

机构地区：[1]蚌埠医学院第一附属医院眼科,安徽蚌埠233004 [2]蚌埠医学院研究生院

出　　处：《齐齐哈尔医学院学报》2022年第22期2162-2166,共5页Journal of Qiqihar Medical University

基　　金：安徽高校自然科学研究项目(KJ2021A0766);蚌埠医学院研究生创新计划(Byycxz21102)。

摘　　要：糖尿病性黄斑水肿(Diabetic macular edema,DME)是糖尿病患者视力下降的常见原因,其特征是黄斑区增厚和囊样水肿。目前DME的发病机制尚不明确,各种治疗方法疗效各异。目前DME的治疗包括药物治疗、激光治疗、手术治疗及联合治疗等。DME是工作年龄糖尿病患者永久性视力丧失的最常见原因,因此寻找准确、可靠的治疗方法成为当前研究的重点。本文就糖尿病性黄斑水肿的治疗进展作一综述。Diabetic macular edema(DME)is a common cause of visual impairment in patients with diabetes and is characterized by thickening of the macular area and cystic edema.At present,the pathogenesis of DME is not clear,and various treatment methods have different efficacy.Current treatments for DME include drug therapy,laser therapy,surgery and combination therapy,etc.DME is the most common cause of permanent vision loss in working-age diabetics,so finding an accurate and reliable treatment is the focus of current research.This article reviews the treatment progress of diabetic macular edema.

关 键 词：糖尿病性黄斑水肿 抗血管内皮生长因子 激光光凝术 玻璃体切割术 新兴治疗 

分 类 号：R774.5[医药卫生—眼科]